Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine Disruptors

Front Immunol. 2020 Sep 2:11:1737. doi: 10.3389/fimmu.2020.01737. eCollection 2020.

Abstract

Osteoporosis stems from an unbalance between bone mineral resorption and deposition. Among the numerous cellular players responsible for this unbalance bone marrow (BM) monocytes/macrophages, mast cells, T and B lymphocytes, and dendritic cells play a key role in regulating osteoclasts, osteoblasts, and their progenitor cells through interactions occurring in the context of the different bone compartments (cancellous and cortical). Therefore, the microtopography of immune cells inside trabecular and compact bone is expected to play a relevant role in setting initial sites of osteoporotic lesion. Indeed, in physiological conditions, each immune cell type preferentially occupies either endosteal, subendosteal, central, and/or perisinusoidal regions of the BM. However, in the presence of an activation, immune cells recirculate throughout these different microanatomical areas giving rise to a specific distribution. As a result, the trabeculae of the cancellous bone and endosteal free edge of the diaphyseal case emerge as the primary anatomical targets of their osteoporotic action. Immune cells may also transit from the BM to the depth of the compact bone, thanks to the efferent venous capillaries coursing in the Haversian and Volkmann canals. Consistently, the innermost parts of the osteons and the periosteum are later involved by their immunomodulatory action, becoming another site of mineral reabsorption in the course of an osteoporotic insult. The novelty of our updating is to highlight the microtopography of bone immune cells in the cancellous and cortical compartments in relation to the most consistent data on their action in bone remodeling, to offer a mechanist perspective useful to dissect their role in the osteoporotic process, including bone damage derived from the immunomodulatory effects of endocrine disrupting chemicals.

Keywords: bone remodeling; endocrine disrupting chemical; immunobiology; immunomodulation; organoid; osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Remodeling / drug effects*
  • Bone and Bones / drug effects*
  • Bone and Bones / immunology
  • Bone and Bones / physiopathology
  • Endocrine Disruptors / adverse effects*
  • Humans
  • Immune System / drug effects*
  • Immune System / immunology
  • Immune System / physiopathology
  • Immunologic Factors / adverse effects*
  • Osteoporosis / chemically induced*
  • Osteoporosis / immunology
  • Osteoporosis / physiopathology

Substances

  • Endocrine Disruptors
  • Immunologic Factors